Charles Schwab Investment Management Inc Bioventus Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Bioventus Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 390,162 shares of BVS stock, worth $4.46 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
390,162
Previous 280,803
38.95%
Holding current value
$4.46 Million
Previous $1.61 Million
188.85%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding BVS
# of Institutions
142Shares Held
45.9MCall Options Held
179KPut Options Held
124K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$149 Million44.65% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$79.2 Million33.68% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.35MShares$49.7 Million3.09% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$27.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$23.7 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $704M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...